Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens
- Conditions
- Refractive Ametropia
- Interventions
- Device: LID015385 soft contact lensesDevice: Comfilcon A soft contact lenses
- Registration Number
- NCT04085328
- Lead Sponsor
- Alcon Research
- Brief Summary
The purpose of this clinical trial is to evaluate the safety and performance of an investigational soft contact lens compared to a commercially available soft contact lens when worn in an extended wear modality.
- Detailed Description
Subjects will be expected to attend 9 office visits. The total expected duration of participation for each subject is approximately 12 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 675
- Able to understand and sign an Informed Consent Form.
- Willing to attend all scheduled study visits as required per protocol.
- Willing and able to wear assigned study lenses as required per protocol.
- Successful wear of spherical daily wear or extended wear frequent replacement soft contact lenses in both eyes during the past 3 months for a minimum of 5 days per week.
- Manifest cylinder ≤ 0.75 diopter (D) in each eye.
- Other protocol-specified inclusion criteria may apply.
- Any eye infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator.
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator.
- History of eye surgery, including refractive surgery.
- Currently pregnant or breast-feeding.
- Monovision contact lens wearers.
- Daily disposable contact lens wearers.
- Other protocol-specified exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description LID015385 LID015385 soft contact lenses LID015385 soft contact lenses worn in both eyes for up to 6 nights/7 days continuously (awake and asleep). Must sleep 1 night per week without lenses. Lenses will be replaced as specified in the study protocol. Biofinity Comfilcon A soft contact lenses Comfilcon A soft contact lenses worn in both eyes for up to 6 nights/7 days continuously (awake and asleep). Must sleep 1 night per week without lenses. Lenses will be replaced as specified in the study protocol.
- Primary Outcome Measures
Name Time Method Distance Visual Acuity (VA) With Study Lenses - Completed Eyes Day 1 Dispense; Hour 24 Follow-Up; Week 1 Follow-up; Month 1 Follow-up; Month 2 Follow-up; Month 3 Follow-up; Month 6 Follow-up; Month 9 Follow-up, Month 12 Follow-up Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No formal hypothesis was formulated for the primary effectiveness endpoint of distance VA; hence, no inferential testing was performed.
Distance Visual Acuity (VA) With Study Lenses - Discontinued Eyes Day 1 Dispense; Hour 24 Follow-Up; Week 1 Follow-up; Month 1 Follow-up; Month 2 Follow-up; Month 3 Follow-up; Month 6 Follow-up; Month 9 Follow-up Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No formal hypothesis was formulated for the primary effectiveness endpoint of distance VA; hence, no inferential testing was performed.
Proportion of Ocular Serious and Significant Non-serious Adverse Device Effects (ADEs) Up to Month 12 Calculated as the total number of eyes reporting at least one treatment-emergent, ocular, serious ADE or treatment-emergent, ocular, significant, non-serious ADE, divided by the total number of eyes enrolled and dispensed. An ADE was defined as any adverse event related to the use of the investigational medical device (LID015385) or control product (Biofinity).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (42)
Kannarr Eye Care, LLC
🇺🇸Pittsburg, Kansas, United States
Complete Eye Care of Medina
🇺🇸Medina, Minnesota, United States
Fischer Laser Eye Center, LLC
🇺🇸Willmar, Minnesota, United States
Complete Family Vision Care
🇺🇸San Diego, California, United States
Kurata Eye Care Center
🇺🇸Los Angeles, California, United States
Westview Optometry
🇺🇸San Diego, California, United States
ProCare Vision Centers, Inc.
🇺🇸Granville, Ohio, United States
Winston Eye Care
🇺🇸Fullerton, California, United States
East West Eye Institute
🇺🇸Los Angeles, California, United States
Kindred Optics at Maitland Vision Center
🇺🇸Maitland, Florida, United States
Alterman, Modi & Wolter
🇺🇸Poughkeepsie, New York, United States
North Spartanburg Eye Center
🇺🇸Boiling Springs, South Carolina, United States
Total Eye Care, PA
🇺🇸Memphis, Tennessee, United States
Dawn M Rakich, OD
🇺🇸San Antonio, Texas, United States
Family EyeCare Center
🇺🇸Campbell, California, United States
Dr.Elsa Pao, O.D
🇺🇸Oakland, California, United States
Gordon Schanzlin New Vision Institute
🇺🇸San Diego, California, United States
Mid Florida Eye Center, PA
🇺🇸Mount Dora, Florida, United States
OMEGA Vision Center PA, DBA Sabal Eye Care
🇺🇸Longwood, Florida, United States
Eola Eyes
🇺🇸Orlando, Florida, United States
Vision Health Institute
🇺🇸Orlando, Florida, United States
Golden Vision
🇺🇸Sarasota, Florida, United States
Advanced Eyecare Specialists
🇺🇸West Palm Beach, Florida, United States
VisionPoint Eye Center
🇺🇸Bloomington, Illinois, United States
Franklin Park Eye Center, PC
🇺🇸Franklin Park, Illinois, United States
Fraser Eye Care Center
🇺🇸Fraser, Michigan, United States
Tekwnai Vision Center, Inc
🇺🇸Saint Louis, Missouri, United States
Dr. Schwartz Optometrist and Associates
🇺🇸Sterling Heights, Michigan, United States
Asheville Eye Associates, PLLC
🇺🇸Asheville, North Carolina, United States
Rochester Ophthalmological Group, PC
🇺🇸Rochester, New York, United States
EyeCare Professionals, Inc. DBA Insight Research Clinic, LLC
🇺🇸Powell, Ohio, United States
Midwest Vision Care
🇺🇸Piqua, Ohio, United States
Wyomissing Optometric Center
🇺🇸Wyomissing, Pennsylvania, United States
West Bay Eye Associates
🇺🇸Warwick, Rhode Island, United States
Advancing Vision Research, LLC
🇺🇸Smyrna, Tennessee, United States
Beaumont Family Eye Care
🇺🇸Beaumont, Texas, United States
Clarke EyeCare Center
🇺🇸Wichita Falls, Texas, United States
Primary Eyecare Group, PC
🇺🇸Brentwood, Tennessee, United States
Vision One Eyecare
🇺🇸Katy, Texas, United States
Optimum Vision Care
🇺🇸Brighton, Massachusetts, United States
Visual Performance Center Research & Development
🇺🇸Pensacola, Florida, United States
Optometry Group, PLLC
🇺🇸Memphis, Tennessee, United States